No CrossRef data available.
Article contents
P01-365 Safety of second-generation antipsychotics in children-questionnaire evaluation in psychiatrists
Published online by Cambridge University Press: 16 April 2020
Abstract
Atypical antipsychotics are more safe than first generation drugs. But some researchers suggest that children and adolescents might be more sensitive than adults to developing antipsychotic-related adverse side effects. The standards of safety monitoring strategies do not exist in Poland.
The aim of this study was to estimate physicians awareness to side effects in youth population treated with antipsychotics.
20 questionnaires filled up by polish child psychiatrists.
Information from author's questionnaire concerns side effects observed in antipsychotics medicated children, psychiatrists own preferences in safety monitoring strategies were analyzed.
Atypical antipsychotics are used in 25% of medicated children. Risperidon is the most popular antipsychotic in psychotic and non-psychotic indications (81%, 66%), afterwards olanzapine (54%, 30%) and quetiapine (34%, 24%). The most common indications for antipsychotics in children are: tics (55%), conduct disorders (53%) and schizophrenia (45%). Before drug initiation doctors check liver enzymes (GOT, GTP) (98%), hematology (98%), glucose level (95%), weight and height (91%), ECG (90%). The most common side effects observed are: weigh gain (63%), somnolence (59%), prolactin elevation (47%), attention deficits (43%).
In spite of lack of safety monitoring standards in youth population psychiatrists seem to be aware and careful in atypical neurolpetic treatment in children.
- Type
- Research Article
- Information
- European Psychiatry , Volume 26 , Issue S2: Abstracts of the 19th European Congress of Psychiatry , March 2011 , pp. 367
- Copyright
- Copyright © European Psychiatric Association2011
Comments
No Comments have been published for this article.